Skip to content Skip to footer

TOP 20

Oncology Companies by Total Products Top 20 2019
Top 20 Oncology Companies by Total Products of 2019
To remain successful in the oncology market- change is now a key to adapt to this altering market dynamics. A recent development in science and technology platforms are likely to grow faster for cancer treatment in comparison to other therapy areas. However- despite robust levels of pipeline activity- oncology remains a challenging area for research…
Innovative Digital Therapeutics Top 20 2019
Top 20 Innovative Digital Therapeutics Companies of 2019
The recent decades have shown an accelerated development and evolution in the technology world- leading to unexpected growth in digital health companies. With the aid of health information technology- wearable devices- telehealth- telemedicine- and personalized medicine HCPs can make better insights for treatments and early diagnosis of life-threatening diseases Our team at PharmaShots has categorized…
Prescription Drugs Top 20 2019
Top 20 Prescription Drugs Based on 2019 Revenue
The average life expectancy span of Human Beings are increased due to better medical facilities and drugs developed by Biopharma companies. Pharmaceutical products or drugs or medicines are being produced for a wide range of medical sectors. It includes the lifesaving drugs or the major therapy area including immunology- cardiology- and neurology but are they…
Biopharma and Govt. Institutions Top 20 2019
Top COVID-19 Deals (Part III): Biopharma and Govt. Institutions
The emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies- as well as government agencies- to partner at unprecedented speed to develop vaccines- treatments- and kits This article covers the last six months of deal data provided by Chris Dokomajilar of DealForma  During the last six months…
Diagnostics Companies Based Top 20 2019
Top 20 Diagnostics Companies Based on 2019 Revenue
Diagnostics has emerged as one of the largest and fastest-growing segments with evolving diseases. The segment has played a vital role in diagnosing growing and ageing global population with increasing health expenditure and more prevalent lifestyle ailments including obesity- cancer- and cardiovascular diseases. Our team at PharmaShots has compiled a list of top 20 diagnostics companies based…
Medical Device Companies Top 20 2019
Top 20 Medical Device Companies Based on 2019 Revenue
The Medical device market is growing with evolving needs of patients and with their emerging diseases encouraging them to develop novel and innovative therapies or devices for maintaining quality of life. The ledger for 2019 of medical devices has shown changes for multiple companies but the position for Medtronic remains same to be one top…
COVID-19 Deals Biopharma Vaccine Development Top 20 2020
Top COVID-19 Deals (Part II): Biopharma Vaccine Development
The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies- as well as government agencies- to partner at unprecedented speed to develop vaccines- treatments- and tests This article covers the last four months of deal data provided by Chris Dokomajilar of DealForma Our team at PharmaShots…
BioPharma Companies based Top 20 2019
Top 20 BioPharma Companies based on 2019 Total Revenue
The global biopharma companies are developing novel therapies & devices which is- in turn- enhancing their portfolio and encouraging them in this undergoing competition to stay in the topmost position The top 20 companies chartbusters changed their 2019 ranking- but the history of Johnson and Johnson did not change and it continued being at the…
COVID-19 Deals Biopharma Drug Top 20 2018
Top COVID-19 Deals (Part I): Biopharma Drug Development
The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies- as well as government agencies- to partner at an unprecedented speed to develop vaccines- treatments- and tests This article covers last four months of deal data provided by Chris Dokomajilar of DealForma. This first part is…